Requests
8
Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
RNatives Inc (Delaware company)Founder and CEO
Feb. 2021Boston, Massachusetts, United StatesThe RNatives is a pre-clinical stage therapeutics company focusing on the commercialization of a unique nuclear-acting miRNA platform for various indications. Our most advanced program is focusing on Heart Failure (HF) and Peripheral Artery Disease (PAD) as target indications. Those are addressed by miRNA-drug upregulating VEGFA gene expression transiently in the target tissue, leading to neovascularization and regeneration of the tissue for therapy.
BiopSense Ltd.Board Member
May. 2020Greater Jyvaskyla AreaBiopSense is medtech company founded in Jyväskylä, Finland. BiopSense was born from a research project at the University of Jyväskylä. The company focuses currently on COVID-19 diagnostics as well as creating a novel technology platform for liquid biopsy sample transportation.
SPARK FinlandSPARK Finland Mentor (Stanford orginated program)
Jan. 2019
Kasve LtdBusiness Advisor
Jan. 2019
AT Medical Affairs Consulting OyBusiness Development Consultant
Jan. 2014 - Oct. 2014EspooEvaluation of the biotechnology business as a potential growth platform for Medaffcon. Executed and delivered pilot projects to test the market. Learned a great deal about how big pharma transforms invention into innovation at the time of market launch from my colleagues at Medaffcon.
Biotech Start-Up Management Ltd.Company Owner and Chairman
Nov. 2013Pyhäjoki, North Ostrobothnia, FinlandBiotech Start-Up Management Oy is providing experienced professional resources for Technology Transfer Offices / Innovation Services for identifying and choosing the right technologies to focus on, how to secure capital for such technologies, accelerating the technology transfer processes by seeking out-licensing options as well as helping with spin-out creation.
Hermo Pharma Ltd.CEO
Feb. 2010 - Oct. 2013Hermo Pharma (currently Herantis) is a CNS-focused biotech company focusing on developing disease-modifying treatments for Parkinson’s disease and Amblyopia in Adults. My duty is as a CEO was to lead the coordination of the R&D, IPR, business development, and fundraising functions. I did raise > 5 million EUR funding for the company and lead the R&D through added value steps. The company valuation was increased by 6x during my time there. I have initialized key negotiations with multiple major industrial companies regarding the commercialization and joint development of the Hermo Pharma ́s technologies and closed one strategic R&D option deal with a major player as well as obtained 2 exit offers as well as prepared the company towards enabling IPO.
PlexPress OyCEO
Jun. 2007 - Jan. 2010PlexPress is a research tool company having a TRAC gene expression analysis technology under development for multiplex medium-throughput gene expression analysis. My work as a CEO included the creation of the business plans, strategies, business models, executive, and financial plans as well as operative goals in collaboration with the management and consultants. I also participated in field sales and marketing of the company products as well as a fundraising activity. I was able to get 10 academic pilot customers for the TRAC technology. And I raised about 2 million EUR funding for the company during my time there. Company valuation went up >100x during my work there. Additionally, I recruited the Scientific Advisory Board at the time for the company from my networks.
University of HelsinkiManager of High Throughput Center
Jul. 2004 - May. 2007High Throughput Center is an academic drug discovery-oriented laboratory. As a manager of the University core facility, I independently built the HTS service from the beginning. I essentially set up the operation, delivered the service, developed the offering, sold and delivered the service for over 40 basic research or discovery phase projects to the local scientists during my time there for the facility which was financially almost double from the goals set.
PerkinElmerQuality Manager and Application Specialist
Mar. 2003 - Jun. 2004I managed the day-to-day quality of the manufacturing of the drug discovery reagents (DELFIA and LANCE technologies). Also delivered customer support function for drug discovery reagents and detection instrument (VICTOR V) as an Application Scientist. I was found prompt at my customer support work and I was pushing the vendors to develop their goods or quality practices for meeting the Wallac standards.
Karolinska InstitutetMaster´s thesis student
Jan. 2000 - Dec. 2001Stockholm, SwedenWorked with Professor Karl Tryggvason and his great team. An excellent period in my career. This resulted in one published article.
Intch is a Professional Networking App for the Future of WorkSee more people like Juhani on Intch
300k+ people
130+ countries
AI matching
Get Intch if you'd like to
248622 people
15
CEO @ Novia Finland Ltd.
40
Managing Partner | Alternative Investment Banking and Funds @ Heliarch
24
Selfemployed @ Equiplan OY
93164 people
15
CEO @ Novia Finland Ltd.
40
Managing Partner | Alternative Investment Banking and Funds @ Heliarch
19
Educational consultant @ Freelancer